Niosomal drug delivery system - a review

International Journal of Applied Pharmaceutics

Volumn 3, Issue 3, 2011, Pages 7-10

  Mujoriya, Rajesh Z ^a   Dhamande, Kishor ^a   Bodla, Ramesh Babu ^b  

^a Sardar Patel College of Technology (BPharmacy)   (India)

^b KRISHNA INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

Liposome; Niosomes; Ophthalmic; Parentral; Targeting; Topical

Indexed keywords

ACETAZOLAMIDE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BLEOMYCIN; DAUNORUBICIN; DICLOFENAC; DORZOLAMIDE; DOXORUBICIN; FLURBIPROFEN; GADOBENATE DIMEGLUMINE; IONIC SURFACTANT; LIPOSOME; METHOTREXATE; MICROSPHERE; NIMESULIDE; NIOSOME; STIBOGLUCONATE SODIUM; TIMOLOL MALEATE; VINCRISTINE;

BIOAVAILABILITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG STABILITY; DRUG STRUCTURE; DRUG TARGETING; EVAPORATION; FILM; FLUIDIZATION; HUMAN; HYDRATION; HYDROPHILICITY; IN VITRO STUDY; INTRAOCULAR PRESSURE; LIPID VESICLE; LIPOPHILICITY; METHODOLOGY; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOSIS; PARTICLE SIZE; REVIEW; SCANNING ELECTRON MICROSCOPY; ULTRASOUND;

EID: 80052280838     PISSN: None     EISSN: 09757058     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Theresa M.A., Drugs published by Adis international Ltd., 1998; 56(5):747-756.
2. Breimer D.D. and Speiser R. Topics in pharmaceutical Sciences. 5 Elsevier Science Publishers, New York, USA. 1985; p.291.
3. Malhotra M. and Jain N.K. Niosomes as Drug Carriers. Indian Drugs (1994), 31 (3): 81-86.
4. Buckton G., Harwood, Interfacial phenomena in Drug Delivery and Targeting Academic Publishers, Switzerland. 1995; p.154-155.
5. Rogerson A., Cummings J., Willmott N. and Florence A.T. The distribution of doxorubicin in mice following administration in niosomes. J Pharm Pharmacol. 1988; 40(5): 337-342.
6. Baillie A.J., Coombs G.H. and Dolan T.F. Non-ionic surfactant vesicles, niosomes, as delivery system for the anti-leishmanial drug, sodium stribogluconate J.Pharm.Pharmacol. 1986; 38: 502-505.
7. Chauhan S. and Luorence M.J. The preparation of polyoxyethylene containing non-ionic surfactant. vesicles. J. Pharm. Pharmacol. 1989; 41: 6p.
8. Chauhan S, Luorence MJ, The preparation of poly-oxyethylene containing non-ionic surfactant vesicles, J. Pharm. Pharmacol, 41, 1989, 6.
9. Yoshioka T, Stermberg B, Florence AT, Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85), International J. Pharm, 105, 1994, 1-6.
10. Gayatri Devi S, Venkatesh P, Udupa N, Niosomal sumatriptan succinate for nasal administration, International J. Pharm. Sci, 62(6), 2000, 479-481.
11. Szoka FJR, Papahadyopoulos D, Comparative properties and methods of preparation of lipid vesicles (liposomes), Ann. Rev. Biophys. Bioeng, 9, 1980, 467-508.
12. Sattuwar PM, Khandare JN, Nande VS, Niosomal delivery of ketoconozole, Indian Drugs, 38(12), 2001, 620-623.
13. Balasubramanium A, Dasaratha DM, Vangala AK, Formulation and In-vitro evaluation of niosomes encapsulated Daunorubicin hydrochloride, Indian Drugs, 39(1), 2002, 27-31
14. Malhotra M. and Jain N.K. Niosomes as Drug Carriers. Indian Drugs (1994), 31 (3): 81-86.
15. Gregoriadis G. Targeting of drugs: implications in medicine. Lancet. 1981; 2(8240): 241-246.
16. Weissman G., Bloomgarden D., Kaplan R., Cohen C., Hoffstein S., Collins T., Gotlieb A. and Nagle D. A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells. Proc. Natl. Acad. Sci.1975; 72(1): 88-92.
17. Cummings J., Staurt J.F. and Calman K.C. Determination of adriamycin, adriamycinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography. J. Chromatogr. 1984; 311: 125-133.
18. Suzuki K. and Sokan K. The Application of Liposomes to Cosmetics. Cosmetic and Toiletries. 1990; 105: 65-78.